4.7 Review

New Therapies of Liver Diseases: Hepatic Encephalopathy

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 18, Pages -

Publisher

MDPI
DOI: 10.3390/jcm10184050

Keywords

cirrhosis; portal-systemic shunt; ammonia; vigilance

Funding

  1. University of Padova

Ask authors/readers for more resources

Hepatic encephalopathy (HE) is a common complication of advanced liver disease with significant implications for patients, families, healthcare services, and society as a whole. The past few years have seen increased attention towards HE and the development of new drugs/management strategies to address this serious management challenge.
Hepatic encephalopathy (HE) is a common complication of advanced liver disease which has profound implications in terms of the patients' ability to fulfil their family and social roles, to drive and to provide for themselves. Recurrent and persistent HE is still a serious management challenge, translating into a significant burden for patients and their families, health services and society at large. The past few years have been characterized by significantly more attention towards HE and its implications; its definition has been refined and a small number of new drugs/alternative management strategies have become available, while others are underway. In this narrative review we summarize them in a pragmatic and hopefully useful fashion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available